Side-by-side financials for ATRA and BNTX. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ATRA | BNTX |
|---|---|---|
| Market cap | - | $22.90 B |
| US-listed rank | - | #572 |
| Revenue (latest FY) | $120.77M | - |
| Net income (latest FY) | $32.69M | - |
| Net margin | 27.1% | - |
| SEC filings | 999 | 548 |
Full pages: Atara Biotherapeutics, Inc. and BioNTech SE, or browse the full rankings.